Vanguard Group’s Anebulo Pharmaceuticals ANEB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
215,951
+11,406
| +6% | +$16.4K | ﹤0.01% | 4014 |
|
|
2025
Q1 | $266K | Buy |
204,545
+50,509
| +33% | +$65.7K | ﹤0.01% | 4012 |
|
|
2024
Q4 | $259K | Hold |
154,036
| – | – | ﹤0.01% | 4061 |
|
|
2024
Q3 | $297K | Buy |
154,036
+163
| +0.1% | +$315 | ﹤0.01% | 4079 |
|
|
2024
Q2 | $420K | Buy |
153,873
+401
| +0.3% | +$1.1K | ﹤0.01% | 4048 |
|
|
2024
Q1 | $440K | Buy |
153,472
+469
| +0.3% | +$1.35K | ﹤0.01% | 4049 |
|
|
2023
Q4 | $370K | Buy |
153,003
+130,659
| +585% | +$316K | ﹤0.01% | 4115 |
|
|
2023
Q3 | $68.3K | Buy |
22,344
+6,312
| +39% | +$19.3K | ﹤0.01% | 4379 |
|
|
2023
Q2 | $37.7K | Buy |
+16,032
| New | +$37.7K | ﹤0.01% | 4487 |
|